Joseph Rizzo
Cardiovascular Disease · Lubbock, TXNPI 1104829639
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,891 and has fallen 93.7% since, to $120 in 2023. That places this record below the midpoint for cardiovascular disease clinicians in TX, where the typical reported total is $3,258.
Across 202 payments — averaging $16.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$589
- Medtronic$589
- Amgen$539
- Amarin Pharma, Inc.$349
- Kowa Pharmaceuticals America, Inc.$291
- Edwards Lifesciences$270
- plus $659 from 15 others
What the payments were for
- Food & beverage$3,287100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 16 | $589 |
| Medtronic(2 entities) | 31 | $589 |
| Amgen | 43 | $539 |
| Amarin Pharma, Inc. | 26 | $349 |
| Kowa Pharmaceuticals America, Inc. | 40 | $291 |
| Edwards Lifesciences | 4 | $270 |
| Johnson & Johnson | 9 | $128 |
| Boehringer Ingelheim | 5 | $72 |
| AstraZeneca | 5 | $66 |
| Cardinal Health 200 LLC | 4 | $66 |
| Sanofi-aventis U.S. LLC | 4 | $61 |
| Abbott | 3 | $59 |
| Gilead | 3 | $41 |
| Pfizer | 2 | $41 |
| Philips North America LLC | 1 | $40 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| Novo Nordisk | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| W. L. Gore & Associates, Inc. | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $13 |
| Bardy Diagnostics, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,287 in reported general payments places this provider in the 50th percentile of 1,515 cardiovascular disease providers in Texas.
Other cardiovascular disease in Lubbock
- Ramin Farzaneh-FarDallas$17.1M
- John OsborneGrapevine$1.3M
- Darren McGuireDallas$1.2M
- Peter McCulloughDallas$664K
- Ann NavarDallas$616K
- Biykem BozkurtHouston$606K
- Milton PackerDallas$530K
- Amarinder BindraDallas$512K
- Robert SalazarKingwood$478K
- Reynolds DelgadoHouston$471K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.